Peru on Monday declared a 90-day national health emergency after a massive spike in cases of a rare neurological disorder – the Guillain-Barre syndrome. According to reports, the country has seen an unusual increase of 165 cases, while four people have died due to the disorder. Peru had also issued an alert on June 27 regarding the increasing cases, said reports.
What is Guillain-Barre syndrome?
The Guillain-Barre syndrome is a rare neurological disorder in which the body’s immune system attacks the nerves. It starts with a tingling sensation and weakness in the hands and feet, and can quickly spread further – ending up paralyzing the body. Most people with this condition need to be hospitalised for the treatment.
While the exact cause of the disorder is not yet known, reports suggested that two-thirds of patients saw symptoms of an infection – Covid-19 or gastrointestinal infection or Zika virus – in the six weeks preceding.
What is the syndrome?
Guillain-Barré syndrome (GBS) is a rare neurological disorder that affects the peripheral nervous system. It is characterized by immune system attacks on nerves, causing inflammation and damage. GBS often follows bacterial or viral infections. Symptoms include muscle weakness, tingling, and loss of reflexes. It can progress to paralysis and impact breathing. Diagnosis involves physical examination, nerve conduction studies, and fluid analysis. Treatment focuses on symptom management and supportive care. Intravenous immunoglobulin therapy and plasmapheresis are common treatments. Recovery can be gradual, requiring rehabilitation and therapy. GBS can be severe but prompt medical intervention and care can lead to significant recovery.
Also Read: Article 370: SC directs day-to-day hearing from Aug 2 of pleas